Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.905 USD | +6.42% | +5.74% | +26.47% |
05-02 | Transcript : Lexicon Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (LXRX) LEXICON PHARMACEUTICALS Posts Q1 Revenue $1.1M, vs. Street Est of $1.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.47% | 647M | |
+4.92% | 109B | |
+10.91% | 105B | |
-0.38% | 22.25B | |
-12.01% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.05% | 16.85B | |
+4.21% | 13.76B | |
+35.12% | 12.46B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Citigroup Adjusts Price Target on Lexicon Pharmaceuticals to $8 From $6, Keeps Buy Rating